CompletedNot Applicable

State Immunization Information Systems to Improve HPV Vaccination Rates

United States77,716 participantsStarted 2017-02-21

Plain-language summary

The overarching goal of this study is to evaluate the effectiveness, cost-effectiveness and sustainability of utilizing statewide Immunization Information Systems (IIS) to conduct centralized reminder/recall (R/R) to improve Human Papiloma Virus (HPV) vaccination rates among adolescents ages 11-17 (with a more focused look at the new two dose series for 11-14 year olds).

Who can participate

Age range11 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 11 through 17 years of age (trial 1) * 11 through 14 years of age (trial 2) * defaulted to our selected clinics within CIIS * is either due for an HPV dose at baseline according to Advisory Committee on Immunization Practices (ACIP) guidelines, or * has initiated but not yet completed the HPV series at baseline Exclusion Criteria: * Has completed the HPV vaccine series according to Advisory Committee on Immunization Practices (ACIP) guidelines * Any child whose parents have requested removal from the immunization registry

What they're measuring

Initiation of the HPV vaccine series (receipt and documentation of initial dose of vaccine series within immunization registry)

Timeframe: 5 months

Completion of the HPV vaccine series (receipt and documentation of final dose of vaccine series within immunization registry)

Timeframe: 5 months

Trial details

NCT IDNCT02993965

SponsorUniversity of Colorado, Denver

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-03-15

View on ClinicalTrials.gov More Vaccine trials